AzTrials
AzTrials

Abortion, HabitualNCT04064931

Nutritional Deficiencies About Recurrent Miscarriage

An observational study of Abortion, Habitual and Nutritional Status, run by Peking Union Medical College Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study plans to recruit patients with recurrent miscarriage and detect their niacin, thiamine, vitamin A, vitamin B6, vitamin B12, vitamin D levels in plasma, evaluating if some lack exists. Read more about this study

Who is it for?
Ages Up to 35 years, women onlyHealthy volunteers can take part
Conditions the study is for
Abortion, Habitual, Nutritional Status
What is being tested?
Detection of niacin and other vitamins in plasma
How many people
1,000 participants
Where
1 siteChina
Study dates
1 Aug 2019to Nov 2022
How long will I take part?
3 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 35 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Study population: Recurrent abortion population without confirmed diagnosis of known causes

Who may be able to join

  • Research group 1: Recurrent abortion group: women of childbearing age who have spontaneous abortion within 20 weeks of pregnancy for 2 or more consecutive times.
  • Control group: 1) Women of childbearing age who had a normal pregnancy history and are not in pregnancy status now. 2) Women of childbearing age in general examination.

Who cannot join

  • patients with confirmed causes unrelated to nutritional deficiencies, including
  • Both husband and wife have been diagnosed with chromosomal abnormalities or fetal chorionic chromosomal abnormalities;
  • The patient has been diagnosed with uterine abnormalities;
  • vaginal bacterial infection or chlamydial infection;
  • antiphospholipid antibody syndrome;
  • Other immune system diseases (hypothyroidism, PCOS, hyperprolactinemia);
Show all 9Show fewer
  • ovarian function decline (FSH>10mIU/ml);
  • Cervical insufficiency5.3 Exit criteria:
  • After being selected, the researcher was withdrawn due to various considerations.

Trial locations and contacts

1 site in 1 country.

Qi Yu, Professor contact

18612671865

yuqi2008001@sina.com

Fangying Chen, MD contact

18800106869

18800106869@163.com

China1 site, 1 recruiting
  • Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, 100730

    Qi Yu, professor, 18612671865, yuqi2008001@sina.com

    Fangying Chen, MD, 18800106869, 18800106869@163.com

    Recruiting

Other trials in China

About this study

Official title: Study on Nutritional Deficiencies and Related Factors in Patients With Recurrent Miscarriage

The study plans to recruit patients with recurrent miscarriage and detect their niacin, thiamine, vitamin A, vitamin B6, vitamin B12, vitamin D levels in plasma, evaluating if some lack exists.

Read the detailed description

Dr. Shi Hongjun from West Lake University has confirmed in a mouse model that a decrease in maternal niacin levels caused by a low niacin diet can lead to stillbirth(HJ Shi, et al. 2017). Due to the lack of a recognized clinical niacin test, it is unclear whether niacin deficiency is associated with abortion. However, some studies have showed: 1. Nearly one-third of pregnant women present low niacin level during the first trimester of pregnancy; 2. Insufficient parent niacin intake is positively correlated with the incidence of congenital heart disease; 3. Vitamin B6 affects niacin metabolism, while maternal B6 deficiency is significantly associated with early abortion. Based on this, the investigators predict that (1) a certain proportion of recurrent abortion women's niacin levels are lower than the normal range of women's normal; (2) supplementation of niacin can reduce the risk of repeated abortion.

There are many methods for detecting niacin, but so far with no reports for large population. Dr. Shi Hongjun from West Lake University used the most sensitive QTRAP 6500+ liquid chromatography tandem mass spectrometer to accurately quantify the concentration of NAD, nicotinamide, niacin and other niacin metabolites in plasma and have optimized the detection process, which would be applicated in this study.

At the same time, studies have shown that pregnant women generally have multiple vitamin deficiency during pregnancy, including plasma thiamine, vitamin A, vitamin B6, vitamin B12 and vitamin D. Therefore, in addition to detecting plasma niacin, this study will also examine the plasma levels of the remaining multivitamins to further explore the impact of nutritional deficiencies on the probability of recurrent miscarriage.

Being tested
Detection of niacin and other vitamins in plasma
Keywords
recurrent miscarriage, vitamins
Medical subject headings
Abortion, Habitual

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Detection of niacin and other vitamins in plasmaDiagnostic test

    Detection of niacin and other vitamins in plasma

Study groups in NCT04064931
Study groupRoleWhat they receive
recurrent abortionwomen of childbearing age who have spontaneous abortion within 20 weeks of pregnancy for 2 or more consecutive times.
Receives: Diagnostic Test: Detection of niacin and other vitamins in plasma
normal pregnancy historyWomen of childbearing age who had a normal pregnancy history and are not in pregnancy status now.
Receives: Diagnostic Test: Detection of niacin and other vitamins in plasma
general populationWomen of childbearing age in general examination.
Receives: Diagnostic Test: Detection of niacin and other vitamins in plasma

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Plasma niacin levels in the enrolled population.

    Measured: 2019-11 to 2020-1

Secondary outcomes (2)
  1. plasma thiamine, vitamin A, vitamin B6, vitamin B12, vitamin D levels of the enrolled population

    Measured: 2019-11 to 2020-1

  2. full exon sequence of the enrolled population

    Measured: 2019-11 to 2020-1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2019
  2. Study start1 Aug 2019
  3. Primary completion12 Nov 2021
  4. Study completionNov 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,000 participants (estimated)
Target duration
3 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT04064931
Sponsor's protocol ID
yuqi2019
Status last verified
Mar 2021
First submitted
20 Aug 2019
Last updated
15 Mar 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The results of outcomes may be presented after the study has been finished.

Questions about this trial

What is this clinical trial studying?

An observational study of Abortion, Habitual and Nutritional Status, run by Peking Union Medical College Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Qi Yu, Professor (18612671865, yuqi2008001@sina.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Plasma niacin levels in the enrolled population. (time frame: 2019-11 to 2020-1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in